Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Drug Alcohol Depend. 2021 Jan 11;220:108525. doi: 10.1016/j.drugalcdep.2021.108525

TABLE 1.

Characteristics of PWID by HCV Antibody Status, 2018 Seattle area NHBS (n=533)

HCV+ (n=376) HCV− (n=157)
N Column % N Column %
Age
  18-29 58 15.4 39 24.8
  30-39 98 26.1 58 36.9
  40-49 90 23.9 32 20.4
  50+ 130 34.6 28 17.8
Gender
  Male 228 60.6 92 58.6
  Female 145 38.6 61 38.9
  Transgender 3 0.8 4 2.6
Race / Ethnicity*
  Am. Indian / Native Am. 96 25.5 23 14.7
  Asian / Pacific Islander 23 6.1 11 7.0
  Black / African Am. 66 17.6 39 24.8
  Hispanic / Latinx 46 12.2 20 12.7
  White 273 72.6 107 68.2
Homeless, current 220 58.5 103 65.6
Primary Drug
  Heroin 266 70.7 101 64.3
  Methamphetamine 39 10.4 38 24.2
  Heroin + Meth 45 12.0 9 5.7
  Other 26 6.9 9 5.7
Medication for Opioid Use Disorder, past 12 months 217 58.5 73 51.8
*

Select all, can sum to >100%